Papers by Jurriën M. ten Berg
Page 2 · newest first
- 2023 European Society of Cardiology guidelines for the management of acute coronary syndromesNetherlands Heart Journal · 2024
- Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on ThrombosisEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2024
- Current and Future Roles of Glycoprotein IIb–IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial InfarctionSHILAP Revista de lepidopterología · 2024
- Continuation versus Interruption of Oral Anticoagulation during TAVINew England Journal of Medicine · 2024
- 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)European Heart Journal · 2024
- 2024 ESC Guidelines for the management of chronic coronary syndromesEuropean Heart Journal · 2024
- Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromesEuroIntervention · 2024
- Antithrombotic therapy for transcatheter structural heart interventionEuroIntervention · 2024
- The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing pieceEuropean Heart Journal · 2024
- Prehospital tirofiban increases the rate of disrupted myocardial infarction in patients with ST-segment elevation myocardial infarction: insights from the On-TIME 2 trialEuropean Heart Journal Acute Cardiovascular Care · 2024
- Association between overweight and obesity with coronary artery bypass graft failure: an individual patient data analysis of clinical trialsEuropean Journal of Cardio-Thoracic Surgery · 2024
- Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus documentEuroIntervention · 2024
- Pre-hospital evaluation of chest pain patients using the modified HEART-score: rationale and designFuture Cardiology · 2024
- Upper extremity versus lower extremity for secondary access during transcatheter aortic valve implantation: rationale and design of the randomised TAVI XS trialNetherlands Heart Journal · 2024
- The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatmentEuropean Heart Journal · 2024
- The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndromeInternational Journal of Cardiology · 2024
- TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationaleAmerican Heart Journal · 2024
- Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular diseaseHeart · 2024
- Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s)Journal of the American Heart Association · 2023
- Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysisNetherlands Heart Journal · 2023
- Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trialEuroIntervention · 2023
- Adding Surgical Edge-to-Edge Mitral Valve Repair to Myectomy in Hypertrophic Obstructive Cardiomyopathy: Long-Term Functional and Echocardiographic OutcomeCurrent Problems in Cardiology · 2023
- Treatment of elderly patients with non-ST-elevation myocardial infarction: the nationwide POPular age registryNetherlands Heart Journal · 2023
- Characteristics and outcomes in patients with a prior myocardial infarction treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings from ALETHEIA, a multi-country observational studyEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2023
- Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age RegistryJournal of Clinical Medicine · 2023
- Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet AggregationJournal of Thrombosis and Thrombolysis · 2023
- Impact of recurrent ischaemic and bleeding events on quality of life in patients with acute coronary syndrome: Insights from the FORCE-ACS registryOpen Heart · 2023
- Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients: Rationale and design of the LEGACY studyAmerican Heart Journal · 2023
- Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-UpCirculation · 2023
- Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research ConsortiumCirculation · 2023
- Sex Differences in Outcomes After Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions · 2023
- Prepercutaneous coronary intervention Zalunfiban dose-response relationship to target vessel blood flow at initial angiogram in st-elevation myocardial infarction – A post hoc analysis of the cel-02 phase IIa studyAmerican Heart Journal · 2023
- External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular diseaseAmerican Heart Journal · 2023
- CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE TrialsAmerican Journal of Cardiovascular Drugs · 2023
- The Clinical Implementation of CYP2C19 Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS RegistryJournal of Cardiovascular Pharmacology and Therapeutics · 2023
- Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trialAmerican Heart Journal · 2022
- Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-studyFrontiers in Pharmacology · 2022
- Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trialsEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2022
- Impact of Smoking Status on Mortality in STEMI Patients Undergoing Mechanical Reperfusion for STEMI: Insights from the ISACS–STEMI COVID-19 RegistryJournal of Clinical Medicine · 2022
- SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical ReperfusionAngiology · 2022
- The incremental value of exercise ECG to myocardial perfusion SPECT for prediction of cardiac eventsEuropean Heart Journal · 2022
- The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertaintiesEuropean Heart Journal · 2022
- Parenteral Antiplatelet Drugs in ST-Elevation Myocardial Infarction: Current Status and Future DirectionsThrombosis and Haemostasis · 2022
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)European Heart Journal · 2022
- 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgeryEuropean Heart Journal · 2022
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)European Heart Journal - Cardiovascular Imaging · 2022
- Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registryRespiratory Research · 2022
- Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft SurgeryJAMA · 2022
- P2Y₁₂-inhibitor monotherapy after coronary stenting: are all P2Y₁₂-inhibitors equal?Expert Review of Cardiovascular Therapy · 2022
- A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial.2022